| Jungyeon Moon, PHARMACIST | |
|
1038 Grand Ave Apt 39n, Diamond Bar, CA 91765-4164 | |
| (909) 973-5019 | |
| Not Available |
| Full Name | Jungyeon Moon |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1038 Grand Ave Apt 39n, Diamond Bar, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124639216 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 82890 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jungyeon Moon, PHARMACIST 1038 Grand Ave Apt 39n, Diamond Bar, CA 91765-4164 Ph: (909) 973-5019 | Jungyeon Moon, PHARMACIST 1038 Grand Ave Apt 39n, Diamond Bar, CA 91765-4164 Ph: (909) 973-5019 |
News Archive
The court released a list of cases it has decided to take up or decline and Virginia's lawsuit regarding the health law was not included. Because the Court releases "a regular list of orders" every Monday it is in session, there was speculation that the justices would act on this issue yesterday.
As a wide variety of nanoparticles continue to demonstrate their ability to improve the delivery of imaging agents and drugs to tumors, nanoparticle researchers have turned their attention to the challenge of systematically determining how a given nanoparticle's physical and chemical characteristics affect its ability to target tumors. Such data could provide drug developers with guidelines to help them select the most effective type of nanoparticle for a given therapeutic or imaging application.
ESMO, the leading European professional organisation for medical oncology, has released new consensus guidelines for the management of metastatic colorectal cancer that reflect an increasingly personalized approach to treatment, as published online today in Annals of Oncology.
Navarre researcher, Jaione Valle Turrillas, has identified two genes that could help as targets for pharmaceutical drugs that fight the Staphylococcus aureus bacteria - one of the bacteria which causes most infections in medical implants.
CTI BioPharma Corp. today announced that it has acquired worldwide rights to tosedostat through concurrent transactions with Vernalis R&D Limited, the originator of tosedostat, and Chroma Therapeutics Ltd., through which CTI previously held a sublicense with respect to tosedostat in North, Central and South America.
› Verified 7 days ago
Sun Joo Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 S Diamond Bar Blvd, Diamond Bar, CA 91765 Phone: 909-861-5551 | |
Tom Li, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 747 Grand Ave, Diamond Bar, CA 91765 Phone: 909-610-2150 | |
Jeeeun Song, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21010 Golden Springs Dr, Diamond Bar, CA 91789 Phone: 909-595-4003 | |
Hyung Ah Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21010 Golden Springs Dr, Diamond Bar, CA 91789 Phone: 909-595-4003 | |
Stanley Liwen Hsu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 S Diamond Bar Blvd, Diamond Bar, CA 91765 Phone: 909-861-5551 | |
Mrs. Afifa W Soliman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 691 Featherwood Dr, Diamond Bar, CA 91765 Phone: 909-815-9995 |